86* Lung function improvement with aztreonam 75 mg powder and solvent for nebuliser solution (AZLI) in a single-arm extension of a randomized trial of inhaled antipseudomonal antibiotics in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa infection

✍ Scribed by B.M. Assael; R. Chiron; R. Fischer; M. Bresnik; S. Lewis; A.B. Montgomery; T. Pressler

• Book ID: 118642997
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 51 KB
• Volume: 10
• Category: Article
• ISSN: 1569-1993
• DOI: 10.1016/s1569-1993(11)60104-5